Aptevo Therapeutics Inc
Research Aptevo Therapeutics Inc (APVO) on Bullrun: market cap USD 5.48M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPVO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.48M
- Financial periodFY2025
- Net income-USD 25.97M
Valuation Snapshot
latest market cap is USD 5.48M.
About Aptevo Therapeutics Inc
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.
Frequently asked questions
What is Aptevo Therapeutics Inc's market cap?
Aptevo Therapeutics Inc's market capitalization is USD 5.48M.
What does Aptevo Therapeutics Inc do?
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.